Bend Bioscience
Courtney Schuler is an accomplished accounting professional with extensive experience in corporate accounting and financial reporting. Currently serving as Associate Director of Corporate Accounting at Bend Bioscience since May 2024, Courtney leads accounting operations, finance transformation, and a technical accounting team. Prior roles include Associate Director of Corporate Accounting at Societal™ CDMO, where responsibilities encompassed SEC reporting and equity plan oversight, and Senior Manager of Financial Reporting at Baudax Bio, focusing on compliance with SEC and GAAP regulations for financial statements. Previous experience includes management positions in external reporting and internal audit at West Pharmaceutical Services and assurance services at PwC. Courtney holds a Bachelor of Science in Accounting from Drexel University.
This person is not in the org chart
This person is not in any teams
Bend Bioscience
Every new drug has challenges to overcome on its journey from discovery to market. With today's more specific targets and more challenging chemical spaces, drug delivery and development often requires an enabling technology. We provide a collaborative R&D approach, specializing in particle engineering, drug delivery, drug development and manufacturing expertise to the pharmaceutical industry. We want to partner with you on your challenging molecule and help bring it to market. How can we help?